CiPPPA is a collaborative not-for-profit initiative that connects stakeholders across the entire pharmaceutical supply chain to develop and deploy solutions for recycling of primary pharmaceutical packaging.
The initiative seeks to revolutionise the primary pharmaceutical packaging industry by championing sustainable practices, fostering collaboration and commitment, and developing solutions free from competition, for the benefit of all.
CiPPPA’s Action Task Forces – focusing on blister, inhaler, and injectable packaging – are pivotal in driving the initiative forward. Led by industry experts, their aim is to leverage and optimise existing solutions for pharmaceutical packaging – scaling them for use nationally.
CiPPPA aims to reshape the management of pharmaceutical packaging and lead the healthcare industry in environmental stewardship. Join us in this groundbreaking initiative to contribute to industry-wide transformation.
In a significant move towards sustainable healthcare, pharmaceutical industry leaders are spearheading efforts to reduce the environmental impact of metered-dose inhalers (MDIs). This motion, highlighted by CiPPPA and its members, showcases the industry’s commitment to combining patient care with environmental responsibility.
In a recent UK parliamentary session, the Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) was highlighted as a key player in the drive towards sustainable healthcare solutions.
We are pleased to announce that Sanofi has joined us as a new CiPPPA member.